Racial/ethnic differences in risk of suicidal ideation and suicide attempts in a nationally representative sample of U.S. adolescents
Journal of Affective Disorders · 2024
DOI: 10.1016/j.jad.2024.08.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2024. Verfasst von Naomi Cruz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Behavior, Society and Policy, Rutgers School of Public Health, Piscataway, NJ, United States of America. Electronic address: Nao…. Hauptthemen laut MEDLINE: Suicidal Ideation, Suicide, Attempted. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Suicidal ideation (SI) and suicide attempts (SA) are risk factors for suicide which peak during adolescence; however, evidence focused on differences in SI and SA risk among racial/ethnic minority youth is limited despite increasing suicide rates among several racial/ethnic minority groups. METHODS: We analyzed a representative sample of adolescents aged 12-17 with prior depressive symptoms (n = 32,617) from the cross-sectional National Surveys on Drug Use and Health (2008-2019). Survey-weighted adjusted logistic regressions estimated the association of race/ethnicity with self-reported lifetime SI and SA, controlling for sociodemographics, lifetime substance use, lifetime major depressive episode, and self-rated health. RESULTS: Compared to white adolescents, Black and Hispanic adolescents had a 2.5 % (p = 0.04) and 4.2 % (p < 0.001) lower likelihood of reporting SI. However, among participants reporting SI, Black and Hispanic adolescents had a 3.2 % (p = 0.03) and 3.1 % (p = 0.03) higher likelihood of reporting SA than white adolescents. Multiracial adolescents were 5.9 % (p = 0.03) more likely to report SA than white adolescents. LIMITATIONS: Although racial/ethnic minority groups are less likely to self-report mental health symptoms, we could only assess SI/SA among adolescents self-reporting prior depressive symptoms, and we could only assess SA among adolescents self-reporting SI due to survey methods. CONCLUSIONS: Variation in the racial/ethnic distribution of suicidality supports theories conceptualizing separate pathways for SI and SA. This underscores the need for greater attention to racial/ethnic differences in suicide-related research, surveillance, and prevention efforts, including ensuring that mental health risk assessments directly evaluate SA in addition to SI in order to better identify high-risk racial/ethnic minority youth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Behavior, Society and Policy, Rutgers School of Public Health, Piscataway, NJ, United States of America. Electronic address: Naomi.Cruz@Rutgers.edu.
- Department of Health Behavior, Society and Policy, Rutgers School of Public Health, Piscataway, NJ, United States of America.
- Department of Health Behavior, Society and Policy, Rutgers School of Public Health, Piscataway, NJ, United States of America; Rutgers Institute for Health, Health Care Policy and Aging Research, New Brunswick, NJ, Unite…
Zitieren
APA
Cruz, N., Duberstein, P., & Samples, H. (2024). Racial/ethnic differences in risk of suicidal ideation and suicide attempts in a nationally representative sample of U.S. adolescents. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.08.034
Vancouver
Cruz N, Duberstein P, Samples H. Racial/ethnic differences in risk of suicidal ideation and suicide attempts in a nationally representative sample of U.S. adolescents. Journal of Affective Disorders. 2024. doi:10.1016/j.jad.2024.08.034
BibTeX
@article{Cruz2024,
author = {Cruz, Naomi and Duberstein, Paul and Samples, Hillary},
title = {Racial/ethnic differences in risk of suicidal ideation and suicide attempts in a nationally representative sample of U.S. adolescents},
journal = {Journal of Affective Disorders},
year = {2024},
doi = {10.1016/j.jad.2024.08.034}
}
EUVIMED